Natera Inc

NASDAQ:NTRA   3:59:50 PM EDT
123.75
+4.07 (+3.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)11.61B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$151.88 Million
Adjusted EPS-$1.30
See more estimates
10-Day MA$121.32
50-Day MA$114.04
200-Day MA$107.77
See more pivots

Natera Inc Stock, NASDAQ:NTRA

13011 McCallen Pass, Building A, Austin, Texas 78753
United States of America
Phone: +1.650.249.9090
Number of Employees: 1815

Description

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.